Senate's Health Bill's Pain Doesn't End at Medicaid
The author thinks BCRA could lead low-income people to pay high prices for awful coverage.
Health Care Investors Are in Denial About Their Risks
The authors says the American Health Care Act could help insurers stop covering dialysis.
Amazon's Long Shadow Falls on the Pharmacy Business
Amazon hopes to become the Amazon.com for the prescription drug market.
Anthem's Earnings Shake Up the Obamacare Narrative
So much for that health insurance market death spiral story.
Trump's Health Care Obsession Will End in Tax Reform Tears
Even for many companies involved with health care, tax laws may matter more than the ACA.
Trump's address left ACA repeal a big mess
The health care goals President Donald Trump mentioned in his address to a joint session of Congress were a high-water mark for policy specificity. But that mark was a low bar.
Pharma's pricing troubles will get worse in 2017
The drug company story of the year is a story about health insurers fighting back.
Aetna's Obamacare brushback is part of the game
Companies often use willingness to participate in a market as a negotiating lever, the author says.
CVS Health has amped up pharma's U.S. drug-price wars
Maybe the PBMs are doing what Congress just wishes it could do.
Anthem, Cigna must plan for a scary future apart
Federal antitrust officials reportedly doubt Anthem and Cigna will be able to create a viable deal. Not-so-secretly applauding are rivals Aetna and Humana.